MDM2 and CDK4 Coexpression Is Uncommon in Sarcomatoid Carcinomas

被引：0
|
作者：
Sukeda, A. [1 ]
Yoshida, A. [1 ]
Yoshida, M. [1 ]
Tsuta, K. [1 ]
Kushima, R. [1 ]
Tsuda, H. [1 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
78
引用
收藏
页码：21A / 22A
页数：2
相关论文
共 50 条
  • [31] Nonsystemic amplification of MYC with CDK4 and MDM2 in a malignant mixed tumor of salivary gland
    Rao, PH
    Murty, VVVS
    Louie, DC
    Chaganti, RSK
    CANCER GENETICS AND CYTOGENETICS, 1998, 105 (02) : 160 - 163
  • [32] Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma
    Ragazzini, P
    Gamberi, G
    Pazzaglia, L
    Serra, M
    Magagnoli, G
    Ponticelli, F
    Ferrari, C
    Ghinelli, C
    Alberghini, M
    Bertoni, F
    Picci, P
    Benassi, MS
    HISTOLOGY AND HISTOPATHOLOGY, 2004, 19 (02) : 401 - 411
  • [33] CDK4和MDM2在脂肪肉瘤诊断中的价值
    朱芸
    周晓军
    诊断病理学杂志, 2012, 19 (01) : 65 - 67
  • [34] Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup
    Martinez-Monleon, Angela
    Oberg, Hanna Kryh
    Gaarder, Jennie
    Berbegall, Ana P.
    Javanmardi, Niloufar
    Djos, Anna
    Ussowicz, Marek
    Taschner-Mandl, Sabine
    Ambros, Inge M.
    Ora, Ingrid
    Sandstedt, Bengt
    Beiske, Klaus
    Ladenstein, Ruth
    Noguera, Rosa
    Ambros, Peter F.
    Murkes, Lena Gordon
    Ljungman, Gustaf
    Kogner, Per
    Fransson, Susanne
    Martinsson, Tommy
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [35] Coordinated expression of MDM2, CDK4 and HMGI-C in atypical lipomatous tumors
    Dei Tos, AP
    Doglioni, C
    Piccinin, S
    Furlanetto, A
    Sciot, R
    Dal Cin, P
    Boiocchi, M
    Fletcher, CDM
    Tallini, G
    MODERN PATHOLOGY, 1998, 11 (01) : 8A - 8A
  • [36] Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma
    Ragazzini, P
    Gamberi, G
    Benassi, MS
    Orlando, C
    Sestini, R
    Ferrari, C
    Molendini, L
    Sollazzo, MR
    Merli, M
    Magagnoli, G
    Bertoni, F
    Bohling, T
    Pazzagli, M
    Picci, P
    CANCER DETECTION AND PREVENTION, 1999, 23 (02): : 129 - 136
  • [37] Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup
    Angela Martinez-Monleon
    Hanna Kryh Öberg
    Jennie Gaarder
    Ana P. Berbegall
    Niloufar Javanmardi
    Anna Djos
    Marek Ussowicz
    Sabine Taschner-Mandl
    Inge M. Ambros
    Ingrid Øra
    Bengt Sandstedt
    Klaus Beiske
    Ruth Ladenstein
    Rosa Noguera
    Peter F. Ambros
    Lena Gordon Murkes
    Gustaf Ljungman
    Per Kogner
    Susanne Fransson
    Tommy Martinsson
    Scientific Reports, 12
  • [38] MicroRNA-129 Inhibits Glioma Cell Growth by Targeting CDK4, CDK6, and MDM2
    Moradimotlagh, Atieh
    Arefian, Ehsan
    Valojerdi, Rezvan Rezazadeh
    Ghaemi, Shokoofeh
    Adegani, Fatemeh Jamshidi
    Soleimani, Masoud
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 19 : 759 - 764
  • [39] Amplification of CDK4 and MDM2 is associated with atypical clinical features in high risk neuroblastoma patients
    Fransson, Susanne M.
    Kryh, Hanna
    Javanmardi, Niloufar
    Ambros, Inge M.
    Berbegall, Ana P.
    Ora, Ingrid
    Noguera, Rosa
    Asmundsson, Jurate
    Sandstedt, Bengt
    Ambros, Peter F.
    Kogner, Per
    Martinsson, Tommy
    CANCER RESEARCH, 2016, 76
  • [40] MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors? A New Perspective
    Clay, Michael R.
    Martinez, Anthony P.
    Weiss, Sharon W.
    Edgar, Mark A.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (12) : 1647 - 1652
12345